show episodes
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
Loading …
show series
 
This week on Biotech Nation, Dr. Noah Davidsohn, Co-Founder and Chief Scientific Officer of Rejuvenate Bio. The discussion centers around the regulation of protein expression and its implications for aging and health. Dr. Davidsohn explains how aging disrupts the balance of protein production, leading to various diseases. Rejuvenate Bio's gene ther…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Semafor Editor-in-Chief and former founding editor-in-chief of Buzzfeed News, Ben Smith, about his book, “Traffic … Genius, Rivalry, and Delusion in the Billion Dollar Race to Go Viral”. Then, Dr. Peter Diamandis, The Executive Chair of the XPrize Foundation, and host of the Moonshots podcast, about ext…
  continue reading
 
This week of BioTech Nation, Dr. Peter Diamandis about his new book, "Longevity: Your Practical Playbook on Sleep, Diet, Exercise, Mindset, Medications, and Not Dying from Something Stupid". We explore his lifelong interest in extending human health span and discuss practical steps for a healthier, longer life, including sleep, diet, exercise, and …
  continue reading
 
On this week’s Tech Nation, Moira speaks with Co-Founder and Co-CEO of NewsGuard, Steven Brill about his book, “The Death of Truth” about the negative impact of the Internet and Social Media and what we can do about it. Then, what science tells us about the treatment potential of Hallucinogens without the hallucinations with, Dr. Sam Clark, CEO of …
  continue reading
 
This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's…
  continue reading
 
This week on Biotech Nation, Dr. Marianne De Backer, CEO of Vir Biotechnology talks about their Phase 2 clinical trials targeting hepatitis B and D co-infections. Vir's approach uses two drugs: tobevibart (an antibody) and elebsiran (an siRNA). These drugs prevent the virus from entering liver cells and stop it from replicating. Preliminary results…
  continue reading
 
Neuroscientist and Author Dr. Kelly Clancy joins me to discuss the role that games have played in human development. Her book is “Playing with Reality … How Games Have Shaped Our World.” Then, Dr. Marianne De Backer, CEO of Vir Biotechnology, explains how serious it can be when a person carries both Hepatitis B and Hepatitis D and what Vir is doing…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Author, Elaine Lin Hering, joins me to talk about her book, “Unlearning Silence … How to Speak Your Mind, Unleash Talent, and Live More Fully.” Then, Dr. Neil Kumar, Founder and CEO of BridgeBio Pharma, explains why we can expect genetic diseases to be solvable in our lifetime.…
  continue reading
 
This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of mu…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Stanford Business School Lecturer, Matt Abrahams, about his book, “THINK FASTER, TALK SMARTER: How To Speak Successfully When You’re Put on the Spot”. Then, Dr. Steffen-Sebastian Bolz from Aphaia Pharma talks about their new drug, currently in phase 3 trial, that may provide the benefits of Ozempic and …
  continue reading
 
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.By Moira Gunn
  continue reading
 
This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved dru…
  continue reading
 
This week we have a best of rerun with Dr. Mark Sumeray from Amolyt Pharma. Dr. Sumeray talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Journalist Alex Kantrowitz about his 2020 book, “Always Day One: How the Tech Titans Plan to Stay on Top Forever” which has spawned his work, as Founder and Editor of Big Technology. Then, Dr. Mark Sumeray, Chief Medical Officer of Amolyt Pharma, talks about their innovative approach to treating hormona…
  continue reading
 
This week Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, discusses advanced health tech. Dr. Kraft highlights his use of wearables like the Apple Watch, Oura ring, and non-invasive blood pressure monitors. He also introduces "otherables," which track health without being worn, using devices like cameras and modified WiFi. These technolog…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Science journalist and author, Annalee Newitz, joins me to talk about her book, “Stories are Weapons … Psychological Warfare and the American Mind”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the latest in Wearables, what they are doing now that they weren’t doing before.…
  continue reading
 
This week on BioTech Nation, Dr. Moira Gunn and Dr. Daniel Kraft discuss how robotics, AI, and virtual reality are transforming surgery. These technologies make procedures less invasive and improve training and outcomes worldwide. Future advancements may include tiny robots performing internal procedures. Security is crucial to prevent hacking of m…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children. Then, Dr. Daniel Kraft, Tech Nati…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Mustafa Suleyman, CEO of Inflection AI, about “The Coming Wave … Technology, Power, and the 21st Century’s Greatest Dilemma”. Then, Bloomberg columnist Adam Minter talks about his 2019 book, “Secondhand: Travels in the New Global Garage Sale.” You dropped it off at the thrift store … where does it go fr…
  continue reading
 
Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three t…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Sports ecology professor and author Dr. Madeleine Orr, about her book, “Warming Up… How Climate Change is Changing Sport”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the Medical Innovation Gap, which is the time from innovation until we actually can use it in everyday prac…
  continue reading
 
Dr. Daniel Kraft, Tech Nation Health Chief Correspondent discusses the gap between medical innovation and its adoption into standard practice. He highlights that it typically takes 17 years for a medical discovery to become common practice, but big data and AI could accelerate this. He emphasizes the importance of sharing medical data and initiativ…
  continue reading
 
This week, Dr. Steve Quake from the Chan Zuckerberg Initiative about their goal to tackle all human diseases in the next century. We discuss CZI's innovative approach, including building Biohubs and funding collaborative research. Dr. Quake explains the importance of something called The Virtual Cell project, aiming to use AI to model every human c…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Pulitzer-Prize winning author, Ed Humes, talks about his book, “Total Garbage… How We Can Fix Our Waste and Heal Our World.” Then, Dr. Steve Quake, Head of Science at the Chan Zuckerberg Initiative tells us about their ambitious goal to address all human diseases within the next century.…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Dr. Neil Kassell, the founder and chair of the Focused Ultrasound Foundation, about what focused ultrasound is and the different ways in which it is being used. Then, Dr. Nicholas Dirks, the President and CEO of the New York Academy of Sciences, talks about such topics as the International Science Reser…
  continue reading
 
This week on Biotech Nation, I speak with Dr. Neal Kassell about focused ultrasound technology. We discuss its noninvasive approach, its diverse applications in treating various medical conditions, and its potential to revolutionize treatments for diseases like Alzheimer's, Parkinson's, and cancer. Dr. Kassell also shares insights into ongoing clin…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Environmental journalist Clayton Page Aldern about his book, “The Weight of Nature … How a Changing Climate Changes Our Brains”. Then, Dr. Sean Bohen, President & CEO of Olema Oncology, talks about what we’ve learned about the 70% of breast cancers, called ER+/HER2- and how it relates to prostate cancer…
  continue reading
 
On this week’s Tech Nation, Moira speaks with journalist Jason Del Rey about Amazon and Walmart - how they are different and their designs on your attention. His book is “Winner Sells All: Amazon, Walmart, and the Battle for Our Wallets”. Then, in biotech, breakthrough science changes the name of the game on how to make a medicine. Dr. Sanjay Shukl…
  continue reading
 
This week on BioTech Nation, we explore new efforts in treating cancer with Dr. Sean Bohen, President and CEO of Olema Oncology. We discuss progress in treating breast cancer, particularly ER+/HER2- breast cancer, which accounts for 70% of diagnoses this year. They examine the biology behind these cancers and how Olema's lead compound, palazestrant…
  continue reading
 
This week - Dr. Sanjay Shukla, CEO of Atyr Pharma, discusses the revolutionary potential of mRNA technology in creating new medicines. They explore Atyr's pioneering approach to leveraging tRNA fragments for treating pulmonary sarcoidosis and other organ-specific conditions, aiming to improve patient outcomes while minimizing reliance on convention…
  continue reading
 
On this week’s Tech Nation, Moira speaks with Warren Berger, author of “A More Beautiful Question … The Power of Inquiry to Spark Breakthrough Ideas” now in its tenth anniversary re-release and update. Then, Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics, tells us about how a treatment can turn into a vaccine and potentially prov…
  continue reading
 
Loading …

Quick Reference Guide